U.S. Markets closed

Bevyxxa - Drug Insights, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships & Sales Forecasting to 2021 - ResearchAndMarkets.com

The "Bevyxxa - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Bevyxxa - Drug Insight, 2019 report provides comprehensive information of the drug, Bevyxxa. It includes drugs overview, Bevyxxa mechanism of action, clinical trials, regulatory milestones, deals & Bevyxxa's partnerships. It further provides Bevyxxa`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Bevyxxa sales till 2021. The report also throws light on Bevyxxa market competition and emerging therapies in the same space as Bevyxxa. Bevyxxa SWOT analysis is also featured.

Scope of the report

  • A comprehensive Bevyxxa overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Bevyxxa Patent information in United States (US) and Europe (EU) has been highlighted
  • Bevyxxa API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Bevyxxa sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Bevyxxa operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Bevyxxa SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Bevyxxa
  • Access to Bevyxxa API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Bevyxxa patents for the major markets- US and EU
  • Understand current and future Bevyxxa`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Bevyxxa
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Bevyxxa
  • Identify opportunities in the same area as with Bevyxxa SWOT analysis

Key Topics Covered

1. Report Introduction

2. Bevyxxa - Overview

  • Bevyxxa Product Description
  • Bevyxxa Route of Synthesis
  • Bevyxxa Mechanism of Action
  • Bevyxxa Pharmacology
  • Bevyxxa Pharmacodynamics
  • Bevyxxa Pharmacokinetics
  • Bevyxxa Adverse Reactions
  • Bevyxxa Clinical Trials
  • Bevyxxa Regulatory Milestones
  • Bevyxxa Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Bevyxxa Global Sales Assessment

  • Bevyxxa Sales Global(Historical)
  • Bevyxxa Sales Global(Forecasted)

6. Bevyxxa Patent Details

7. Bevyxxa Market Competition

8. Bevyxxa Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Bevyxxa SWOT Analysis

List of Tables

Table 1: Bevyxxa, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Bevyxxa Product Details, United States

Table 8: Bevyxxa Product Details, Europe

Table 9: Bevyxxa, Historical Global Sales till 2017 (in million USD)

Table 10: Bevyxxa, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Bevyxxa

Table 12: Bevyxxa Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Bevyxxa

Figure 2: Bevyxxa, Historical Global Sales till 2017 (in million USD)

Figure 3: Bevyxxa, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Bevyxxa

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/na09jq

View source version on businesswire.com: https://www.businesswire.com/news/home/20191227005257/en/


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900